GlassScriptPhysician profile
Edith F Durand
NPI 1457515702
$3,680.01
in general payments reported to CMS, 2019-2025
18 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $620 · 2023: $1,121 · 2024: $1,364 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,857.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $635.44 | 2022-2025 | |
| Neurelis, INC. | $632.54 | 2021-2024 | Valtoco |
| Novartis Pharmaceuticals Corporation | $259.66 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $246.81 | 2022-2023 | |
| Phathom Pharmaceuticals, INC. | $224.97 | 2024 | Voquezna |
| Novo Nordisk INC | $224.71 | 2024-2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $217.97 | 2024 | Airsupra, Farxiga |
| Teva Pharmaceuticals USA, INC. | $202.98 | 2022-2024 | Austedo Xr |
| Hologic Sales and Service, LLC | $156.70 | 2024 | Aptima |
| Dexcom, INC. | $133.27 | 2023 | Dexcom G7 Gss (161) |
| Abbott Laboratories | $127.45 | 2023 | Freestyle Libre 3 |
| Inspire Medical Systems, INC. | $109.96 | 2024 | Inspire |
| Idorsia Pharmaceuticals US INC | $100.00 | 2023 | Quviviq |
| Gilead Sciences, INC. | $100.00 | 2023 | Epclusa |
| Merck Sharp & Dohme LLC | $97.37 | 2023 | Verquvo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $83.66 | 2022 | |
| Genzyme Corporation | $77.24 | 2021 | |
| Lundbeck LLC | $49.28 | 2023 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edith Durand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.